Nvidia invests $50 million in biotech company Recursion for A.I. drug discovery
Publishing timestamp: 2023-07-12 17:22:00
Summary
Chipmaker Nvidia is investing $50 million in Recursion Pharmaceuticals to accelerate the development of the biotech firm's AI models for drug discovery. Recursion will use its large datasets to train its AI models on Nvidia's cloud platform. The investment is part of Nvidia's focus on AI, and Recursion's stock soared following the announcement. Other AI-driven drugmakers also saw an increase in their stock prices.
Sentiment: POSITIVE
Tickers: GOOGL, ROG-CH, MRNA, ABCL, NVDA, BAYN-DE, EXAI, RXRX,
Keywords: exscientia plc, moderna inc, abcellera biologics inc, alphabet inc, technology, nvidia corp, breaking news: technology, health care industry, biotechnology, recursion pharmaceuticals llc, chris gibson, roche holding ag, bayer ag, biotech and pharmaceuticals, pharmaceuticals, business, business news,